ARLTS1 | CC vs. TT | TC vs. TT | CC + TC vs. TT | CC vs. TC + TT | ||||
---|---|---|---|---|---|---|---|---|
Cys148Arg | OR (95% CI) | Ph | OR (95% CI) | Ph | OR (95% CI) | Ph | OR (95% CI) | Ph |
Total | 1.27(1.15,1.41) | 0.088 | 1.10(0.96,1.25) | 0.008 | 1.13(1.02,1.27) | 0.039 | 1.16(1.00,1.35) | 0.003 |
Controls source | ||||||||
Population | 1.38(1.22,1.55) | 0.330 | 1.10(0.95,1.27) | 0.033 | 1.16(1.03,1.30) | 0.135 | 1.26(1.07,1.49) | 0.019 |
Hospital | 1.00(0.81,1.23) | 0.476 | 1.09(0.76,1.57) | 0.012 | 1.06(0.78,1.45) | 0.027 | 0.94(0.79,1.12) | 0.739 |
Study quality | ||||||||
High | 1.35(1.16,1.57) | 0.264 | 1.10(0.94,1.32) | 0.005 | 1.14(1.00,1.31) | 0.049 | 1.14(0.96,1.35) | 0.009 |
Low & Moderate | 1.30(1.07,1.58) | 0.023 | 1.05(0.84,1.31) | 0.185 | 1.12(0.87,1.45) | 0.088 | 1.24(0.86,1.79) | 0.037 |
Type of cancer | ||||||||
Familial | 1.26(1.12,1.43) | 0.060 | 1.11(0.93,1.33) | 0.050 | 1.15(1.02,1.29) | 0.065 | 1.21(0.98,1.49) | 0.018 |
Sporadic | 1.36(1.18,1.55) | 0.797 | 1.08(0.91,1.29) | 0.022 | 1.13(1.02,1.25) | 0.203 | 1.22(1.02,1.46) | 0.050 |